4//SEC Filing
Templeman Blaine 4
Accession 0001567619-18-002684
CIK 0001435049other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 7:29 PM ET
Size
6.8 KB
Accession
0001567619-18-002684
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2018-09-13$6.50/sh−6,056$39,360→ 141,381 total - Award
Common Stock
2018-09-12+77,500→ 147,437 total
Footnotes (3)
- [F1]Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2018.
- [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001653641
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 7:29 PM ET
- Size
- 6.8 KB